Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Surprising Prognosis for Normal ACS

St elevation acute coronary syndromes are typically caused by thrombotic obstruction of a coronary artery due to ruptured atherosclerosis plaque.

Sorpresivo pronóstico para los infartos con coronarias normales

However, there is a significant number of patients with similar clinical presentations but no evidence of obstructive coronary artery disease (CAD).


Read also: CTO in patients with acute myocardial infarction increases long term mortality.


In general, patients without obstructive CAD have better survival, but this might vary substantially depending on the underlying cause and risk factors.

 

The present study included 4793 consecutive patients undergoing ST elevation MI.  88% of these patients had obstructive CAD (≥50% stenosis), 6% had no obstructive CAD (1-49% stenosis) and 5% presented absolutely normal coronary arteries.

 

Patients without CAD were mostly young women with few risk factors. Follow up reached mean 2.6 years.


Read also: Primary angioplasty and multivessel lesions: how should we proceed?


Short term mortality (30 days) was lower both for patients with non-obstructive CAD (HR 0.49; p=0.0018) and for patients with normal coronary arteries (HR 0.31; p=0.021), compared to patients with obstructive CAD.

 

But surprisingly (and just the opposite of what was observed at 30 days) long term mortality with non-obstructive CAD resulted similar (HR 1.15; p=0.48), and for those with normal coronary arteries, it resulted significantly higher (HR 2.44; p<0.001) than that of patients with typical MI (even after adjusting by troponin level).

 

Cause of death was cardiovascular in 70% of cases with typical infarction, but in patients with non-obstructive CAD, it was only 38%, and 32% in patients with normal arteries.


Read also: Is Emergency Cardiac Surgery Necessary in TAVR?


In a population matched by sex and age, mortality resulted superior in patients with non-obstructive CAD.

 

Conclusion

Patients undergoing ST elevation MI that do not present significant obstruction to their coronary arteries have similar and even superior mortality than patients with typical MI. These data suggest that treating these patients involve far more than the routine angiography, and that it should include medication and close follow-up.

 

Original title: Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease.

Reference: Hedvig Bille Andersson et al. Eur Heart J. 2018 Jan 7;39(2):102-110.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...